Radius Health, Inc. RDUS announced positive top-line data from the phase III ATOM study which is evaluating its lead product, Tymlos (abaloparatide 80 mg subcutaneous [“SC”]) injection, for use in men ...
Radius Health ("Radius" or "the Company"), a specialty biopharmaceutical company dedicated to bone health and related therapeutic areas, including through its lead product TYMLOS® (abaloparatide) ...
Radius Health (NASDAQ:RDUS) on Wednesday said it had entered into new agreements for the expansion of its Tymlos injection to treat osteoporosis - a condition in which bones become weak and brittle - ...
TYMLOS®demonstrated a lower incidence of hip fracture and non-vertebral fracture compared to teriparatide in women with osteoporosis 50 years and older (n=43,352) in this analysis of ...
WALTHAM, Mass., March 18, 2019 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS), a science-driven fully integrated biopharmaceutical company that is committed to developing and commercializing ...
Labatec Pharma SA: Switzerland and the MENA region including Bahrain, Iraq, Jordan, Kuwait, Oman, Qatar, Saudi Arabia, UAE, Algeria, and Morocco Pharmbio Korea Inc.: South Korea Biosidus: Colombia, ...
WALTHAM, Mass., March 17, 2018 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq:RDUS), a science-driven fully integrated biopharmaceutical company that is committed to developing and commercializing ...
Label change aligns with strategic focus on postmenopausal women at high risk of fracture Danielle Holtschlag joins as Head of Sales, bringing 20 years of experience to the team Added ~3,000 new ...
ATOM study met the primary endpoint of change in lumbar spine bone mineral density at 12 months (p-value < 0.0001) Study also met secondary endpoints relating to bone mineral density changes in lumbar ...
Full-Year 2019 TYMLOS U.S. net revenue exceeds financial guidance, surpassing $172M. TYMLOS exits 2019 with 52% market share in new patients1, on track for market leadership in 2020. Radius delivers ...
Unopened Tymlos pens should be stored in the refrigerator to maintain the effectiveness of the active ingredient. Once a Tymlos pen is opened, it can be stored at room temperature for up to 30 days, ...
Subscribe to The St. Louis American‘s free weekly newsletter for critical stories, community voices, and insights that matter. When you hear about osteoporosis, what kind of patient do you picture?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback